Staff Publications: March 2018

1. Aelion CM, Airhihenbuwa CO, Alemagno S, et al. The US Cancer Moonshot Initiative. Lancet Oncol. 2016;17(5):e178-180. PMID: 27301041. Letter.

2. Agarwal N, Pal SK, Hahn AW, et al. Characterization of Metastatic Urothelial Carcinoma Via Comprehensive Genomic Profiling of Circulating Tumor DNA. Cancer. 2018. PMID: 29517810.

3. Auerbach MV, Heckman CJ, Darlow S. To Protect or Not to Protect: Examining Reasons for Sun Protection among Young Women at Risk for Skin Cancer. J Behav Med. 2018. PMID: 29589257.

4. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol 2018;73:262-70. European Urology. 2018;73(4):E98-E99. Letter.

5. Bayarmagnai B, Perrin L, Esmaeili Pourfarhangi K, Gligorijevic B. Intravital Imaging of Tumor Cell Motility in the Tumor Microenvironment Context. Methods Mol Biol. 2018;1749:175-193. PMID: 29525998.

6. Bevelacqua JJ, Welsh J, Mortazavi SMJ, Doss M. Comments on “Radiation Induced Breast Cancer Risk in Brca Mutation Carriers from Low-Dose Radiological Exposures: A Systematic Review”: Radioprotection 52(4), 231-240, Doi: 10.1051/Radiopro/2017034. Radioprotection. 2018;53(1):67-68.

7. Brown JR, Hamadani M, Hayslip J, et al. Voxtalisib (Xl765) in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia: An Open-Label, Phase 2 Trial. Lancet Haematol. 2018;5(4):e170-e180. PMID: 29550382.

8. Buller DB, Heckman CJ, Manne SL. The Potential of Behavioral Counseling to Prevent Skin Cancer. JAMA Dermatol. 2018. PMID: 29558529.

9. Cartmell KB, Sterba KR, Pickett K, et al. Availability of Patient-Centered Cancer Support Services: A Statewide Survey of Cancer Centers. PLoS One. 2018;13(3):e0194649. PMID: 29584744.

10. Caruso LB, Martin KA, Lauretti E, et al. Poly(Adp-Ribose) Polymerase 1, Parp1, Modifies Ezh2 and Inhibits Ezh2 Histone Methyltransferase Activity after DNA Damage. Oncotarget. 2018;9(12):10585-10605. PMID: 29535829. PMC5828221.

11. Chen M, Zheng L, Santra B, et al. Hydroxide Diffuses Slower Than Hydronium in Water Because Its Solvated Structure Inhibits Correlated Proton Transfer. Nat Chem. 2018;10(4):413-419. PMID: 29531374.

12. Cheng Z, Shen X, Jiang X, et al. Hyperhomocysteinemia Potentiates Diabetes-Impaired Edhf-Induced Vascular Relaxation: Role of Insufficient Hydrogen Sulfide. Redox Biol. 2018;16:215-225. PMID: 29524844. PMC5854893.

13. Chhatre S, Jefferson A, Cook R, et al. Patient-Centered Recruitment and Retention for a Randomized Controlled Study. Trials. 2018;19(1):205. PMID: 29587805. PMC5870194.

14. Christopher Z, Binitie O, Henderson-Jackson E, Perno J, Makanji RJ. Langerhans Cell Histiocytosis of Bone in an Adult: A Case Report. Radiology Case Reports. 2018;13(2):310-314.

15. Correa AF, Handorf E, Joshi SS, et al. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. Journal of Urology. 2018.

16. Correa AF, Toussi A, Amin M, et al. Small Renal Masses in Close Proximity to the Collecting System and Renal Sinus Are Enriched for Malignancy and High Fuhrman Grade and Should Be Considered for Early Intervention. Clin Genitourin Cancer. 2018. PMID: 29500151.

17. Eskander RN, Kauderer J, Tewari KS, et al. Correlation between Surgeon’s Assessment and Radiographic Evaluation of Residual Disease in Women with Advanced Stage Ovarian Cancer Reported to Have Undergone Optimal Surgical Cytoreduction: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2018. PMID: 29550184.

18. Fareed MM, Ishtiaq R, Galloway TJ. Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers. Curr Treat Options Oncol. 2018;19(4):17. PMID: 29527638.

19. Forastiere AA, Fisher SG, Wolf GT. Reply to L. Licitra Et Al. J Clin Oncol. 2018:Jco2018778316. PMID: 29558279.

20. Ge Y, Voelz VA. Model Selection Using Biceps: A Bayesian Approach for Force Field Validation and Parameterization. J Phys Chem B. 2018. PMID: 29518328.

21. Gradishar WJ, Anderson BO, Balassanian R, et al. Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(3):310-320.

22. Guo P, Xue HY, Wong HL. Therapeutic Nanotechnology for Bone Infection Treatment – State of the Art. Curr Drug Deliv. 2018. PMID: 29493453.

23. Hamilton ZA, Uzzo RG, Larcher A, et al. Comparison of Functional Outcomes of Robotic and Open Partial Nephrectomy in Patients with Pre-Existing Chronic Kidney Disease: A Multicenter Study. World J Urol. 2018. PMID: 29532222.

24. Heath EI, Lynce F, Xiu J, et al. Racial Disparities in the Molecular Landscape of Cancer. Anticancer Res. 2018;38(4):2235-2240. PMID: 29599344.

25. Hoppe RT, Advani RH, Ai WZ, et al. Nccn Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw. 2018;16(3):245-254. PMID: 29523663.

26. Hyman DM, Rizvi NA, Natale RB, et al. Phase I Study of Medi3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. Clin Cancer Res. 2018. PMID: 29559563.

27. Indio V, Astolfi A, Tarantino G, et al. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (Gist) Harboring the Rare D842v Mutation in Pdgfra Gene. Int J Mol Sci. 2018;19(3). PMID: 29510530.

28. Joshi SS, Handorf E, Strauss D, et al. Treatment Trends and Outcomes for Patients with Lymph Node-Positive Cancer of the Penis. JAMA Oncol. 2018. PMID: 29494739.

29. Kasagi Y, Chandramouleeswaran PM, Whelan KA, et al. The Esophageal Organoid System Reveals Functional Interplay between Notch and Cytokines in Reactive Epithelial Changes. Cell Mol Gastroenterol Hepatol. 2018;5(3):333-352. PMID: 29552622. PMC5852293.

30. Kelly AD, Madzo J, Madireddi P, et al. Demethylator Phenotypes in Acute Myeloid Leukemia. Leukemia. 2018. PMID: 29556023.

31. Khan N, Kahl B. Targeting Bcl-2 in Hematologic Malignancies. Target Oncol. 2018. PMID: 29520705.

32. Kim SM, Nguyen TT, Ravi A, et al. Pten Deficiency and Ampk Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells. Cancer Discov. 2018. PMID: 29572236.

33. Kinde MN, Bondarenko V, Granata D, et al. Fluorine-19 Nmr and Computational Quantification of Isoflurane Binding to the Voltage-Gated Sodium Channel Nachbac. Proc Natl Acad Sci U S A. 2016;113(48):13762-13767. PMID: 27856739. PMC5137747.

34. Kishan AU, Cook RR, Ciezki JP, et al. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer. Jama. 2018;319(9):896-905. PMID: 29509865.

35. Klaassen Z, Arora K, Goldberg H, et al. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. Journal of Urology. 2018;199(4):906-914.

36. Lazar S, Goldfinger LE. Platelet Microparticles and Mirna Transfer in Cancer Progression: Many Targets, Modes of Action, and Effects across Cancer Stages. Front Cardiovasc Med. 2018;5:13. PMID: 29564336. PMC5850852.

37. Lev A, Lulla AR, Ross BC, et al. Onc201 Targets Ar and Ar-V7 Signaling, Reduces Psa, and Synergizes with Everolimus in Prostate Cancer. Mol Cancer Res. 2018. PMID: 29588330.

38. Li PX, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Medicine. 2018;7(1):75-86.

39. Lucas JW, Ghiraldi E, Ellis J, Friedlander JI. Endoscopic Management of Ureteral Strictures: An Update. Curr Urol Rep. 2018;19(4):24. PMID: 29500521.

40. Lyu RM, Cowan A, Zhang Y, et al. Phoenixin: A Novel Brain-Gut-Skin Peptide with Multiple Bioactivity. Acta Pharmacol Sin. 2018. PMID: 29542680.

41. Makhov P, Naito S, Haifler M, et al. The Convergent Roles of Nf-Kappab and Er Stress in Sunitinib-Mediated Expression of Pro-Tumorigenic Cytokines and Refractory Phenotype in Renal Cell Carcinoma. Cell Death Dis. 2018;9(3):374. PMID: 29515108. PMC5841329.

42. Masselli E, Carubbi C, Cambo B, et al. The -2518 a/G Polymorphism of the Monocyte Chemoattractant Protein-1 as a Candidate Genetic Predisposition Factor for Secondary Myelofibrosis and Biomarker of Disease Severity. Leukemia. 2018. PMID: 29568096.

43. McCullough LL, Connell Z, Xin H, et al. Functional Roles of the DNA-Binding Hmgb Domain in the Histone Chaperone Fact in Nucleosome Reorganization. J Biol Chem. 2018. PMID: 29514976.

44. McDevitt S, Rusanov T, Kent T, Chandramouly G, Pomerantz RT. How Rna Transcripts Coordinate DNA Recombination and Repair. Nat Commun. 2018;9(1):1091. PMID: 29545568. PMC5854605.

45. Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF. Role of Radical Prostatectomy in Metastatic Prostate Cancer: A Review. Urol Oncol. 2017;35(4):125-134. PMID: 28190749.

46. Mishra OP, Popov AV, Pietrofesa RA, Nakamaru-Ogiso E, Andrake M, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (Lgm2605) Inhibits Myeloperoxidase Activity in Inflammatory Cells. Biochim Biophys Acta. 2018;1862(6):1364-1375. PMID: 29524540.

47. Morgans AK, Chen YH, Sweeney CJ, et al. Quality of Life During Treatment with Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J Clin Oncol. 2018:Jco2017753335. PMID: 29522362.

48. Mortazavi S, Mortazavi S. Comment on ‘Cell Phone Use and Ill Health: Is There a Definite Relationship?’. South African Family Practice. 2018:1-2.

49. Mortazavi SMJ. Re: Revisiting the Alerting Effect of Light; a Systematic Review. Sleep Med Rev. 2018. PMID: 29519607.

50. Mortazavi SMJ, Doss M. Comments on “High Radon Areas and Lung Cancer Prevalence: Evidence from Ireland”. J Environ Radioact. 2018. PMID: 29602599.

51. Mortazavi SMJ, Mortazavi SAR, Paknahad M. Cancers of the Brain and Cns: Global Patterns and Trends in Incidence. Journal of Biomedical Physics and Engineering. 2018;8(1):I-II.

52. Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced Renal-Cell Carcinoma. N Engl J Med. 2018. PMID: 29562145.

53. Natarajaseenivasan K, Cotto B, Shanmughapriya S, et al. Astrocytic Metabolic Switch Is a Novel Etiology for Cocaine and Hiv-1 Tat-Mediated Neurotoxicity. Cell Death Dis. 2018;9(4):415. PMID: 29549313.

54. Owonikoko TK, Borghaei H. Immunotherapy of Lung Cancer. J Thorac Dis. 2018;10(Suppl 3):S395-s396. PMID: 29593884. PMC5861270.

55. Peng HZ, Prokop J, Karar J, et al. Familial and Somatic Bap1 Mutations Inactivate Asxl1/2-Mediated Allosteric Regulation of Bap1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Research. 2018;78(5):1200-1213.

56. Phipps AI, Shi Q, Zemla TJ, et al. Physical Activity and Outcomes in Patients with Stage Iii Colon Cancer: A Correlative Analysis of Phase Iii Trial Ncctg N0147 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29563133.

57. Pourfarhangi KE, Bergman A, Gligorijevic B. Ecm Cross-Linking Regulates Invadopodia Dynamics. Biophys J. 2018;114(6):1455-1466. PMID: 29590602.

58. Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High Rate of over-Staging of Barrett’s Neoplasia with Endoscopic Ultrasound: Systemic Review and Meta-Analysis. Dig Liver Dis. 2018. PMID: 29573963.

59. Reese AC, Wessel SR, Fisher SG, Mydlo JH. Evidence of Prostate Cancer “Reverse Stage Migration” toward More Advanced Disease at Diagnosis: Data from the Pennsylvania Cancer Registry. Urol Oncol. 2016;34(8):335.e321-338. PMID: 27108226.

60. Riddle DL, Jensen MP, Ang D, Slover J, Perera R, Dumenci L. Do Pain Coping and Pain Beliefs Associate with Outcome Measures before Knee Arthroplasty in Patients Who Catastrophize About Pain? A Cross-Sectional Analysis from a Randomized Clinical Trial. Clin Orthop Relat Res. 2018;476(4):778-786. PMID: 29543659.

61. Ristau BT, Chen DYT, Ellis J, et al. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. Journal of Urology. 2018;199(4):969-975.

62. Rose JJ, Del Monte J, Groman A, et al. Chemotherapy Extravasation Establishing a National Benchmark for Incidence among Cancer Centers. Clinical Journal of Oncology Nursing. 2017;21(4):438-445.

63. Ross KC, Chin KF, Kim D, Marion CD, Yen TJ, Bhattacharjee V. Methotrexate Sensitizes Drug-Resistant Metastatic Melanoma Cells to Braf V600e Inhibitors Dabrafenib and Encorafenib. Oncotarget. 2018;9(17):13324-13336. PMID: 29568360. PMC5862581
.
64. Sanku RKK, John JS, Salkovitz M, Ilies MA, Walker EA. Potential Learning and Memory Disruptors and Enhancers in a Simple, 1-Day Operant Task in Mice. Behav Pharmacol. 2018. PMID: 29570113.

65. Silva RS, Kido LA, Montico F, Vendramini-Costa DB, Pilli RA, Cagnon VHA. Steroidal Hormone and Morphological Responses in the Prostate Anterior Lobe in Different Cancer Grades after Celecoxib and Goniothalamin Treatments in Tramp Mice. Cell Biol Int. 2018. PMID: 29603508.

66. Siminoff LA, Gardiner HM, Wilson-Genderson M, Shafer TJ. How Inaccurate Metrics Hide the True Potential for Organ Donation in the United States. Prog Transplant. 2018;28(1):12-18. PMID: 29592635.

67. Siminoff LA, Wilson-Genderson M, Mosavel M, et al. Impact of Cognitive Load on Family Decision Makers’ Recall and Understanding of Donation Requests for the Genotype-Tissue Expression (Gtex) Project. J Clin Ethics. 2018;29(1):20-30. PMID: 29565794.

68. Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients. Health Psychology. 2018;37(3):218-227.

69. Teixeira-Poit SM, Halpern MT, Kane HL, Keating M, Olmsted M. Factors Influencing Professional Life Satisfaction among Neurologists. BMC Health Serv Res. 2017;17(1):409. PMID: 28629403. PMC5477134.

70. Teye EK, Sido A, Xin P, et al. Pign Gene Expression Aberration Is Associated with Genomic Instability and Leukemic Progression in Acute Myeloid Leukemia with Myelodysplastic Features. Oncotarget. 2017;8(18):29887-29905. PMID: 28187452. PMC5444711.

71. Tripicchio GL, Ammerman AS, Ward DS, et al. Clinical-Community Collaboration: A Strategy to Improve Retention and Outcomes in Low-Income Minority Youth in Family-Based Obesity Treatment. Child Obes. 2018. PMID: 29584452.

72. von Massenhausen A, Tonnus W, Himmerkus N, et al. Phenytoin Inhibits Necroptosis. Cell Death Dis. 2018;9(3):359. PMID: 29500402. PMC5834524.

73. Vyfhuis MAL, Burrows WM, Bhooshan N, et al. Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance with High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559292.

74. Weinberg DS, Pickhardt PJ, Bruining DH, et al. Computed Tomography Colonography Vs Colonoscopy for Colorectal Cancer Surveillance after Surgery. Gastroenterology. 2018;154(4):927-+.

75. Winer A, Bodor JN, Borghaei H. Identifying and Managing the Adverse Effects of Immune Checkpoint Blockade. J Thorac Dis. 2018;10(Suppl 3):S480-s489. PMID: 29593893. PMC5861268.

76. Yadav RK, Jablonowski CM, Fernandez AG, et al. Histone H3g34r Mutation Causes Replication Stress, Homologous Recombination Defects and Genomic Instability in S. Pombe. Elife. 2017;6. PMID: 28718400. PMC5515577.

77. Zendejas B, Jakub JW, Terando AM, et al. Laparoscopic Skill Assessment of Practicing Surgeons Prior to Enrollment in a Surgical Trial of a New Laparoscopic Procedure. Surg Endosc. 2017;31(8):3313-3319. PMID: 27928664.

78. Zhang Z, Remsing RC, Chakraborty H, et al. Light-Induced Dilation in Nanosheets of Charge-Transfer Complexes. Proc Natl Acad Sci U S A. 2018. PMID: 29581284.

79. Zibelman M, Plimack ER. Immunotherapy for Metastatic Urothelial Carcinoma: Putting the Brakes on Releasing the Brake. Immunotherapy. 2018;10(6):423-425. PMID: 29562856.

80. Zou ZW, Liu T, Li Y, et al. Melatonin Suppresses Thyroid Cancer Growth and Overcomes Radioresistance Via Inhibition of P65 Phosphorylation and Induction of Ros. Redox Biol. 2018;16:226-236. PMID: 29525603. PMC5854931.

81. Zou ZW, Ma C, Medoro L, et al. Lncrna Anril Is up-Regulated in Nasopharyngeal Carcinoma and Promotes the Cancer Progression Via Increasing Proliferation, Reprograming Cell Glucose Metabolism and Inducing Side-Population Stem-Like Cancer Cells. Oncotarget. 2016;7(38):61741-61754. PMID: 27557514. PMC5308687.

82. Zuniga SA, Ebersole B, Jamal N. Utility of Eating Assessment Tool-10 in Predicting Aspiration in Patients with Unilateral Vocal Fold Paralysis. Otolaryngol Head Neck Surg. 2018:194599818762328. PMID: 29529920.

Advertisements

Staff Publications: February 2018

1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointestinal Endoscopy. 2018.

2. Abbosh PH, Plimack ER. Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer. Bladder Cancer. 2018;4(1):9-18. PMID: 29430503. PMC5798524.

3. Adamsky MA, Boysen WR, Cohen AJ, et al. Evaluating the Role of Postoperative Oral Antibiotic Administration in Artificial Urinary Sphincter and Inflatable Penile Prosthesis Explantation: A Nationwide Analysis. Urology. 2018;111:92-98.

4. Al-Kawas F, Aslanian H, Baillie J, et al. Percutaneous Transhepatic Vs. Endoscopic Retrograde Biliary Drainage for Suspected Malignant Hilar Obstruction: Study Protocol for a Randomized Controlled Trial. Trials. 2018;19(1):108. PMID: 29444707. PMC5813390.

5. Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of Rac1-Driven Malignant Melanoma by Group a Pak Inhibitors. Oncogene. 2018;37(7):944-952.

6. Atkins MB, Plimack ER, Puzanov I, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-Randomised, Open-Label, Dose-Finding, and Dose-Expansion Phase 1b Trial. Lancet Oncol. 2018. PMID: 29439857.

7. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2017.06.013. Eur Urol. 2017.

8. Barr PM, Li H, Burack WR, et al. R-Chop, Radioimmunotherapy, and Maintenance Rituximab in Untreated Follicular Lymphoma (Swog S0801): A Single-Arm, Phase 2, Multicentre Study. Lancet Haematol. 2018. PMID: 29396094.

9. Bartel MJ, Puri R, Brahmbhatt B, et al. Correction To: Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29468272.

10. Bartel MJ, Puri R, Brahmbhatt B, et al. Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29392469.

11. Bradbury AR, Patrick-Miller LJ, Egleston BL, et al. Randomized Noninferiority Trial of Telephone Vs in-Person Disclosure of Germline Cancer Genetic Test Results. J Natl Cancer Inst. 2018. PMID: 29490071.

12. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018. PMID: 29398153.

13. Carqueijeiro I, Duge de Bernonville T, Lanoue A, et al. A Bahd Acyltransferase Catalyzing 19-O-Acetylation of Tabersonine Derivatives in Roots of Catharanthus Roseus Enables Combinatorial Synthesis of Monoterpene Indole Alkaloids. Plant J. 2018. PMID: 29438577.

14. Cheng D, Zhao S, Tang H, et al. Microrna-20a-5p Promotes Colorectal Cancer Invasion and Metastasis by Downregulating Smad4. Oncotarget. 2016;7(29):45199-45213. PMID: 27286257. PMC5216716.

15. Churilla TM, DeMora L, Handorf E, et al. Deviations from Standard Chemoradiation among Early-Stage Anal Cancer Patients. Int J Radiat Oncol Biol Phys. 2018;100(4):945-949. PMID: 29485073.

16. Czyz M, Toma M, Gajos-Michniewicz A, et al. Parp1 Inhibitor Olaparib (Lynparza) Exerts Synthetic Lethal Effect against Ligase 4-Deficient Melanomas. Oncotarget. 2016;7(46):75551-75560. PMID: 27705909. PMC5342760.

17. Doss M. Comment on ’30 Years Follow-up and Increased Risks of Breast Cancer and Leukaemia after Long-Term Low-Dose-Rate Radiation Exposure’. Br J Cancer. 2018. PMID: 29438374.
18. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156.

19. Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal Trends and Characteristics of Clinical Trials for Which Only One Racial or Ethnic Group Is Eligible. Contemporary Clinical Trials Communications. 2018;9:135-142.

20. Elliott B, Zackery DL, Eaton VA, et al. Ethnic Differences in Tgfbeta Signaling Pathway May Contribute to Prostate Cancer Health Disparity. Carcinogenesis. 2018. PMID: 29474521.

21. Erkmen CP, Moore RF, Belden C, et al. Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience. Int J Cancer Oncol. 2017;4(2). PMID: 29399636. PMC5796669. NIHMS888832.

22. Escudier B, Sharma P, McDermott DF, et al. Erratum to “Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962-71]. Eur Urol. 2018.

23. Fahl SP, Coffey F, Kain L, et al. Role of a Selecting Ligand in Shaping the Murine Gammadelta-Tcr Repertoire. Proc Natl Acad Sci U S A. 2018;115(8):1889-1894. PMID: 29432160.

24. Fang CY, Tseng M. Ethnic Density and Cancer: A Review of the Evidence. Cancer. 2018. PMID: 29411868.

25. Frankel AS, Bass SB, Patterson F, Dai T, Brown D. Sexting, Risk Behavior, and Mental Health in Adolescents: An Examination of 2015 Pennsylvania Youth Risk Behavior Survey Data. J Sch Health. 2018;88(3):190-199. PMID: 29399839.

26. Fundakowski CE, Hales NW, Agarwal N, et al. Surgical Management of the Recurrent Laryngeal Nerve in Thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck. 2018. PMID: 29461666.

27. Gerhard GS, Fisher SG, Feldman AM. Genetic Testing for Inherited Cardiac Diseases in Underserved Populations of Non-European Ancestry: Double Disparity. JAMA Cardiol. 2018. PMID: 29490336.

28. Giri VN, Knudsen KE, Kelly WK, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology. 2018;36(4):414-424.

29. Godwin JL, Hoffman-Censits J, Plimack E. Recent Developments in the Treatment of Advanced Bladder Cancer. Urol Oncol. 2018. PMID: 29395952.

30. Goetz A, Nweze N, Joshi A, Farma J. Synchronous Subcutaneous Granular Cell Tumours, a Rare Presentation. Ann R Coll Surg Engl. 2018:e1-e3. PMID: 29484942.

31. Gordon RE, Zhang L, Peri S, et al. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Clin Cancer Res. 2018. PMID: 29437795.

32. Haifler M, Pence I, Sun Y, et al. Discrimination of Malignant and Normal Kidney Tissue with Short Wave Infra-Red Dispersive Raman Spectroscopy. J Biophotonics. 2018. PMID: 29411949.

33. Handorf EA, Heitjan DF, Bekelman JE, Mitra N. Estimating Cost-Effectiveness from Claims and Registry Data with Measured and Unmeasured Confounders. Stat Methods Med Res. 2018:962280218759137. PMID: 29468944.

34. Handra-Luca A, Wei S. Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association? Surg Today. 2018. PMID: 29460127.

35. Harshman LC, Chen YH, Liu G, et al. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation with or without Docetaxel. Journal of Clinical Oncology. 2018;36(4):376-382.

36. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. Cb002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein Noxa. Cell Cycle. 2018:1-11.

37. Horwitz SM, Ansell SM, Ai WZ, et al. T-Cell Lymphomas, Version 2.2018 Featured Updates to the Nccn Guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2018;16(2):123-135.

38. Jain R, Dotan E. Nutrition and Aging: A Practicing Oncologist’s Perspective. Current Oncology Reports. 2017;19(11).

39. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerging Infectious Diseases. 2018;24(3):584-587.

40. Karlova MG, Volokh OI, Chertkov OV, Kirpichnikov MP, Studitsky VM, Sokolova OS. Purification and Concentration of Rna Polymerase on Ni-Lipid Monolayers. Russian Journal of Bioorganic Chemistry. 2017;43(6):658-663.

41. Kasimova MA, Yazici A, Yudin Y, et al. Ion Channel Sensing: Are Fluctuations the Crux of the Matter? J Phys Chem Lett. 2018:1260-1264. PMID: 29439562.

42. Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL. Preoperative Predictors That Impact the Survival and Outcome of Patients Undergoing Secondary Cytoreduction for Ovarian Cancer. J Obstet Gynaecol. 2018:1-7. PMID: 29385863.

43. Kishan AU, Shaikh T, Wang PC, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated with Radiotherapy or Radical Prostatectomy: A Multi-Institutional Comparative Analysis. Eur Urol. 2017;71(5):766-773. PMID: 27452951.

44. Koch C, Schwing AM, Herrmann E, et al. Bevacizumab-Based First-Line Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer: An Individual Patient Data Based Meta-Analysis. Oncotarget. 2018;9(12):10272-10283.

45. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(2):170-199.

46. Lee CT, Dong Y, Li T, et al. Local Control and Toxicity of External Beam Reirradiation with a Pulsed Low-Dose-Rate Technique. Int J Radiat Oncol Biol Phys. 2018;100(4):959-964. PMID: 29485075.

47. Localio AR, Goodman SN, Meibohm A, et al. Statistical Code to Support the Scientific Story. Ann Intern Med. 2018. PMID: 29404564.

48. Lounsbury N, Eidem T, Colquhoun J, et al. Novel Inhibitors of Staphylococcus Aureus Rnpa That Synergize with Mupirocin. Bioorg Med Chem Lett. 2018. PMID: 29463447.

49. Majtan T, Jones W, Jr., Krijt J, et al. Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Mol Ther. 2017. PMID: 29398487.

50. Marty R, de Prisco N, Carter H, Font-Burgada J. Mhc-I Genotype Drives Early Immune Selection of Oncogenic Mutations. Mol Cell Oncol. 2018;5(2):e1409863. PMID: 29487895. PMC5821412.

51. Matthew EM, Yang Z, Peri S, et al. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but Not Adenomas: Relationship to Mtor Signaling. Neoplasia. 2018;20(3):244-255. PMID: 29448085.

52. Mehren MV, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-143.

53. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing Donor Site Closure Following Bilateral Breast Reconstruction with Abdominal-Based Free Flaps. Journal of Plastic Reconstructive and Aesthetic Surgery. 2018;71(2):269-271.

54. Mortazavi SAR, Mortazavi SMJ. Women with Hereditary Breast Cancer Predispositions Should Avoid Using Their Smartphones, Tablets, and Laptops at Night. Iran J Basic Med Sci. 2018;21(2):112-115. PMID: 29456806. PMC5811748.

55. Mortazavi SMJ. Cell Phones, Cancer, and Other Problems. Physics Teacher. 2018;56(3):131.

56. Mortazavi SMJ. Comments on “Physician Knowledge of Radiation Exposure and Risk in Medical Imaging”. J Am Coll Radiol. 2018. PMID: 29398502.

57. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body -Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

58. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body Γ-Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

59. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, et al. Letter to the Editor (August 24, 2017) Concerning the Paper “Occupational Exposure to Radon for Underground Tourist Routes in Poland: Doses to Lung and the Risk of Developing Lung Cancer”. Int J Occup Med Environ Health. 2018. PMID: 29416140.

60. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. International Archives of Occupational and Environmental Health. 2018;91(2):247-247.

61. Moten AS, Movva S, von Mehren M, et al. Granular Cell Tumor Experience at a Comprehensive Cancer Center. Journal of Surgical Research. 2018;226:1-7.

62. Naaman H, Rabinski T, Yizhak A, et al. Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells. Cell Reprogram. 2018;20(1):17-26. PMID: 29412740. PMC5804099.

63. Nikonova AS, Deneka AY, Kiseleva AA, et al. Ganetespib Limits Ciliation and Cystogenesis in Autosomal-Dominant Polycystic Kidney Disease (Adpkd). Faseb j. 2018:fj201700909R. PMID: 29401581.

64. Norquist BM, Brady MF, Harrell MI, et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in Gog 218: An Nrg Oncology/Gynecologic Oncology Group Study. Clinical Cancer Research. 2018;24(4):777-783.

65. Overman MJ, Morris V, Moinova H, et al. Phase I/Ii Study of Azacitidine and Capecitabine/Oxaliplatin (Capox) in Refractory Cimp-High Metastatic Colorectal Cancer: Evaluation of Circulating Methylated Vimentin. Oncotarget. 2016;7(41):67495-67506. PMID: 27542211. PMC5341892.

66. Ozdemir AY, Rusanov T, Kent T, Siddique LA, Pomerantz RT. Polymerase Theta-Helicase Efficiently Unwinds DNA and Rna-DNA Hybrids. J Biol Chem. 2018. PMID: 29444826.

67. Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, et al. Increased Phosphorylation of Eif2alpha in Chronic Myeloid Leukemia Cells Stimulates Secretion of Matrix Modifying Enzymes. Oncotarget. 2016;7(48):79706-79721. PMID: 27802179. PMC5346746.

68. Prabhu VV, Talekar MK, Lulla AR, et al. Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone Onc201 in Hematological Malignancies. Cell Cycle. 2018:1-11.

69. Randhawa S, Moore RF, DiSesa V, et al. Role of Thoracic Surgeons in Lung Cancer Screening: Opportune Time for Involvement. J Thorac Oncol. 2018;13(3):298-300. PMID: 29472053.

70. Riddle DL, Ghomrawi H, Jiranek WA, Dumenci L, Perera RA, Escobar A. Appropriateness Criteria for Total Knee Arthroplasty: Additional Comments and Considerations. J Bone Joint Surg Am. 2018;100(4):e22. PMID: 29462044.

71. Ristau BT, Kutikov A. Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance Editorial Comments. Journal of Urology. 2018;199(3):639-640.

72. Sartor O, Vogelzang NJ, Sweeney C, et al. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First US Experience from an Expanded Access Program. Oncologist. 2018;23(2):193-202.

73. Schmier J, Ogden K, Nickman N, et al. Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-Based Infusion Center Setting. Clin Ther. 2017;39(8):1600-1617. PMID: 28716293.

74. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2017;26(4):472-475. PMID: 28325736. PMC5380532. NIHMS853745.

75. Seeger C. Control of Viral Transcripts as a Concept for Future Hbv Therapies. Curr Opin Virol. 2018;30:18-23. PMID: 29453098.

76. Seliga A, Lee MH, Fernandes NC, et al. Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation. Front Immunol. 2018;9:156. PMID: 29456540. PMC5801412.

77. Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients with Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncology. 2018;4(2).

78. Soboloff J, Gligorijevic B, Zaidi MR. Stim1 (C)Amps up Melanogenesis. Embo j. 2018. PMID: 29449324.

79. Toland AE, Forman A, Couch FJ, et al. Clinical Testing of Brca1 and Brca2: A Worldwide Snapshot of Technological Practices. npj Genomic Medicine. 2018;3(1).

80. Toma M, Skorski T, Sliwinski T. DNA Double Strand Break Repair – Related Synthetic Lethality. Curr Med Chem. 2018. PMID: 29421999.

81. Westerberg BD, Lango MN. Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America. Otolaryngol Clin North Am. 2018. PMID: 29482920.

82. Winer A, Nicholas Bodor J, Borghaei H. Identifying and Managing the Adverse Effects of Immune Checkpoint Blockade. Journal of Thoracic Disease. 2018;10:S480-S489.

83. Wu HC, Do C, Andrulis IL, et al. Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. Epigenetics. 2018:1-23. PMID: 29436922.

84. Xiao X, Putatunda R, Zhang Y, et al. Lymphotoxin Beta Receptor-Mediated Nfkappab Signaling Promotes Glial Lineage Differentiation and Inhibits Neuronal Lineage Differentiation in Mouse Brain Neural Stem/Progenitor Cells. J Neuroinflammation. 2018;15(1):49. PMID: 29463313. PMC5819232.

85. Xu K, Yang WY, Nanayakkara GK, et al. Gata3, Hdac6, and Bcl6 Regulate Foxp3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg. Front Immunol. 2018;9:45. PMID: 29434588. PMC5790774.

86. Yamazaki J, Jelinek J, Hisamoto S, Tsukamoto A, Inaba M. Dynamic Changes in DNA Methylation Patterns in Canine Lymphoma Cell Lines Demonstrated by Genome-Wide Quantitative DNA Methylation Analysis. Vet J. 2018;231:48-54. PMID: 29429487.

87. Yu JQ, Doss M, Alpaugh RK. Normal Variants and Pitfalls Encountered in Pet Assessment of Gynecologic Malignancies. PET Clin. 2018;13(2):249-268. PMID: 29482753.

Staff Publications: January 2018

1. Alberro JA, Ballester B, Deulofeu P, et al. Long-Term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer: Meta-Analysis of Individual Patient Data from Ten Randomised Trials. Lancet Oncology. 2018;19(1):27-39.

2. Bai T, Chanda AK, Egleston BL, Vucetic S. Joint Learning of Representations of Medical Concepts and Words from Ehr Data. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2017;2017:764-769. PMID: 29375929. PMC5783648. NIHMS928144.

3. Balasubramanian S, Rajagopalan M, Bojja RS, Skalka AM, Andrake MD, Ramaswamy A. The Conformational Feasibility for the Formation of Reaching Dimer in ASV and HIV Integrase: A Molecular Dynamics Study. Journal of Biomolecular Structure & Dynamics. 2017;35(16):3469-3485.

4. Bevelacqua JJ, Mortazavi SMJ. Commentary: Human Pathophysiological Adaptations to the Space Environment. Front Physiol. 2017;8:1116. PMID: 29358922. PMC5766677.

5. Brigle K, Rogers B. Pathobiology and Diagnosis of Multiple Myeloma. Seminars in Oncology Nursing. 2017;33(3):225-236.

6. Bryant KG, Chae YC, Martinez RL, et al. A Mitochondrial-Targeted Purine-Based Hsp90 Antagonist for Leukemia Therapy. Oncotarget. 2017;8(68):112184-112198. PMID: 29348817. PMC5762502.

7. Coccia PF, Pappo AS, Beaupin L, et al. Adolescent and Young Adult Oncology, Version 2.2018. Journal of the National Comprehensive Cancer Network. 2018;16(1):66-97.

8. Crawford J, Becker PS, Armitage JO, et al. Myeloid Growth Factors, Version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(12):1520-1541.

9. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer Journal for Clinicians. 2018;68(1):64-89.

10. Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Influence of Occupation on Self-Perceived Vocal Problems in Patients with Voice Complaints. Journal of Voice. 2017.

11. Fareed MM, Eldib AA, Weiss SE, Hayes SB, Li J, Ma CC. A Treatment Planning Comparison between a Novel Rotating Gamma System and Robotic Linear Accelerator Based Intracranial Stereotactic Radiosurgery/Radiotherapy. Phys Med Biol. 2018. PMID: 29300187.

12. Galal Osman A, Elokely KM, Yadav VK, et al. Bioactive Products from Singlet Oxygen Photooxygenation of Cannabinoids. Eur J Med Chem. 2018;143:983-996. PMID: 29232588.

13. Galluzzi L, Vitale I, Aaronson SA, et al. Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018. PMID: 29362479.

14. Geynisman DM, Abbosh PH, Plimack ER, Zibelman M. Chemoimmunotherapy in Metastatic Urothelial Carcinoma. Eur Urol. 2018. PMID: 29331216.

15. Ghatalia P, Pond GR, Templeton AJ, Sonpavde G. Effect of Single-Agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-Resistant Prostate Cancer: Pooled Analysis of Prospective Studies. Clin Genitourin Cancer. 2017. PMID: 29352714.

16. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593.

17. Gray HJ, Bell-McGuinn K, Fleming GF, et al. Phase I Combination Study of the Parp Inhibitor Veliparib Plus Carboplatin and Gemcitabine in Patients with Advanced Ovarian Cancer and Other Solid Malignancies. Gynecol Oncol. 2018. PMID: 29352572.

18. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. Journal of Urology. 2018.

19. Haldane A, Flynn WF, He P, Levy RM. Coevolutionary Landscape of Kinase Family Proteins: Sequence Probabilities and Functional Motifs. Biophys J. 2018;114(1):21-31. PMID: 29320688.

20. Han H, Pan M, Tao Y, et al. Early Enteral Nutrition Is Associated with Faster Post-Esophagectomy Recovery in Chinese Esophageal Cancer Patients: A Retrospective Cohort Study. Nutr Cancer. 2018:1-8. PMID: 29313724.

21. Hsieh FK, Kozlova AL, Gerasimova NS, Kotova EY, Formosa T, Studitsky VM. Role of the Nhp6 Protein in in Vitro Transcription through the Nucleosome. Moscow University Biological Sciences Bulletin. 2017;72(4):218-221.

22. Huang X, Qin X, Yang W, et al. Mthfr Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment. Arterioscler Thromb Vasc Biol. 2018. PMID: 29371246.

23. Jackson WC, Dess RT, Litzenberg DW, et al. A Multi-Institutional Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy (Sbrt) Using Continuous Real-Time Evaluation of Prostate Motion with Patient-Reported Quality of Life. Pract Radiat Oncol. 2018;8(1):40-47. PMID: 29304991.

24. Jung K, Ghatalia P, Litwin S, et al. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clin Genitourin Cancer. 2017;15(3):E337-E343.

25. Kayser K, Acquati C, Reese JB, Mark K, Wittmann D, Karam E. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-Oncology. 2018;27(1):13-21.

26. Keohane CE, Steele AD, Fetzer C, et al. Promysalin Elicits Species-Selective Inhibition of Pseudomonas Aeruginosa by Targeting Succinate Dehydrogenase. J Am Chem Soc. 2018. PMID: 29300464.

27. Kumar SK, Callander NS, Alsina M, et al. Nccn Guidelines Insights: Multiple Myeloma, Version 3.2018. J Natl Compr Canc Netw. 2018;16(1):11-20. PMID: 29295877.

28. Kyriakopoulos CE, Chen YH, Carducci MA, et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase Iii E3805 Chaarted Trial. J Clin Oncol. 2018:Jco2017753657. PMID: 29384722.

29. Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD. S-Adenosylhomocysteine Hydrolase over-Expression Does Not Alter S-Adenosylmethionine or S-Adenosylhomocysteine Levels in Cbs Deficient Mice. Molecular Genetics and Metabolism Reports. 2018;15:15-21.

30. Li P, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Medicine. 2018;7(1):75-86.

31. Li PD, Chen P, Peng X, Ma C, Zhang WJ, Dai XF. Hoxc6 Predicts Invasion and Poor Survival in Hepatocellular Carcinoma by Driving Epithelial-Mesenchymal Transition. Aging (Albany NY). 2018. PMID: 29348394.

32. Li X, Shao Y, Sha X, et al. Il-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3k14 (Histone 3 Lysine 14). Arterioscler Thromb Vasc Biol. 2018. PMID: 29371247.

33. Lyubitelev AV, Studitsky VM, Feofanov AV, Kirpichnikov MP. Effect of Sodium and Potassium Ions on Conformation of Linker Parts of Nucleosomes. Moscow University Biological Sciences Bulletin. 2017;72(3):146-150.

34. Maifrede S, Martinez E, Nieborowska-Skorska M, et al. Mll-Af9 Leukemias Are Sensitive to Parp1 Inhibitors Combined with Cytotoxic Drugs. Blood Adv. 2017;1(19):1467-1472. PMID: 29296788. PMC5728460.

35. Mikropoulos C, Selkirk CGH, Saya S, et al. Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men with Genetic Predisposition. Br J Cancer. 2018;118(2):266-276. PMID: 29301143.

36. Mortazavi SM. Comment on “Mobile Phone Radiofrequency Exposure Has No Effect on DNA Double Strand Breaks (Dsb) in Human Lymphocytes”. Annals of Translational Medicine. 2017;5(21).

37. Mortazavi SMJ. Re: Are Electromagnetic Fields in Incubators a Risk Factor for Autism? Acta Paediatrica, International Journal of Paediatrics. 2017;106(12):2063.

38. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, Welsh J, Doss M. Comments on “Space: The Final Frontier-Research Relevant to Mars”. Health Phys. 2018;114(3):344-345. PMID: 29360711. PMC5784783. NIHMS920226.

39. Myers VD, Tomar D, Madesh M, et al. Haplo-Insufficiency of Bcl2-Associated Athanogene 3 in Mice Results in Progressive Left Ventricular Dysfunction, Beta-Adrenergic Insensitivity and Increased Apoptosis. J Cell Physiol. 2018. PMID: 29323723.

40. O’Malley D, Dewan AA, Ohman-Strickland PA, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psycho-Oncology. 2018;27(1):132-140.

41. Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program from Theory through Implementation and Assessment. Rehabilitation Oncology. 2017;35(4):172-180.

42. Petrov R, Bakhos C, Abbas AE. Management of Malignant Lung Entrapment, the Oncothorax. Thoracic Surgery Clinics. 2018;28(1):81-+.

43. Reyngold M, Niland J, ter Veer A, et al. Trends in Intensity Modulated Radiation Therapy Use for Locally Advanced Rectal Cancer at National Comprehensive Cancer Network Centers. Advances in Radiation Oncology. 2018.

44. Ristau BT, Kutikov A. Editorial Comment. Journal of Urology. 2018.

45. Roboz GJ, Kantarjian HM, Yee KWL, et al. Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia. Cancer. 2018;124(2):325-334.

46. Sariyer R, De-Simone FI, Gordon J, Sariyer IK. Immune Suppression of Jc Virus Gene Expression Is Mediated by Srsf1. J Neurovirol. 2016;22(5):597-606. PMID: 26951564. PMC5014737. NIHMS766632.

47. Shadman M, Li H, Rimsza L, et al. Continued Excellent Outcomes in Previously Untreated Patients with Follicular Lymphoma after Treatment with Chop Plus Rituximab or Chop Plus (131)I-Tositumomab: Long-Term Follow-up of Phase Iii Randomized Study Swog-S0016. J Clin Oncol. 2018:Jco2017745083. PMID: 29356608.

48. Tagai EK, Miller SM, Kutikov A, et al. Prostate Cancer Patients’ Understanding of the Gleason Scoring System: Implications for Shared Decision-Making. J Cancer Educ. 2018. PMID: 29333577.

49. Tong C, Simhan J. Delayed Reconstruction of Bulbar Urethral Strictures Is Associated with Multiple Interventions, Longer Strictures and More Complex Repairs Editorial Comment. Journal of Urology. 2018;199(2):521-521.

50. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-+.

51. Wagner J, Kline CL, Zhou L, Khazak V, El-Deiry WS. Anti-Tumor Effects of Onc201 in Combination with Vegf-Inhibitors Significantly Impacts Colorectal Cancer Growth and Survival in Vivo through Complementary Non-Overlapping Mechanisms. J Exp Clin Cancer Res. 2018;37(1):11. PMID: 29357916.

52. Wahab A, Kesari K, S JS, Liu Y, Barta SK. Type B Lactic Acidosis, an Uncommon Paraneoplastic Syndrome. Cancer Biol Ther. 2018;19(2):101-104. PMID: 29293400.

53. Wang Y, Tian H, Cai W, et al. Tracking Hematopoietic Precursor Division Ex Vivo in Real Time. Stem Cell Res Ther. 2018;9(1):16. PMID: 29361987.

54. Ward WH, Manstein SM, Goel N, et al. Optimal Preoperative Assessment of the Geriatric Patient. Perioperative Care and Operating Room Management. 2017;9:33-38.

55. Ward WH, Sigurdson ER, Esposito AC, et al. Pathologic Response Following Treatment for Locally Advanced Rectal Cancer: Does Location Matter? Journal of Surgical Research. 2018;224:215-221.

56. Xiao Q, Ludwig AK, Romano C, et al. Exploring Functional Pairing between Surface Glycoconjugates and Human Galectins Using Programmable Glycodendrimersomes. Proc Natl Acad Sci U S A. 2018. PMID: 29382751.

57. Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Skin Cancer Brachytherapy Vs External Beam Radiation Therapy (Scribe) Meta-Analysis. Radiother Oncol. 2018. PMID: 29370985.

58. Zeng Y, Hahn S, Stokes J, et al. Pak2 Regulates Myeloid-Derived Suppressor Cell Development in Mice. Blood Adv. 2017;1(22):1923-1933. PMID: 29296839. PMC5728145.

Staff Publications: December 2017

1. Ang C, Shields A, Xiu J, et al. Molecular Characteristics of Hepatocellular Carcinomas from Different Age Groups. Oncotarget. 2017;8(60):101591-101598. PMID: 29254188. PMC5731898.

2. Barbe MF, Krueger JJ, Loomis R, Otte J, Gordon J. Memory Deficits, Gait Ataxia and Neuronal Loss in the Hippocampus and Cerebellum in Mice That Are Heterozygous for Pur-Alpha. Neuroscience. 2016;337:177-190. PMID: 27651147. PMC5458736. NIHMS861948.

3. Bartel MJ, Srivastava A, Gordon S, Rothstein RI, Pohl H. Subsquamous Intestinal Metaplasia Is Common in Treatment-Naive Barrett’s Esophagus. Gastrointestinal Endoscopy. 2018;87(1):67-74.

4. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We Cast It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.

5. Boushra M, Tous S, Fetih G, Xue HY, Tran NT, Wong HL. Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery. J Pharm Sci. 2016;105(5):1733-1740. PMID: 27012226.

6. Carnevale V, Klein ML. Small Molecule Modulation of Voltage Gated Sodium Channels. Curr Opin Struct Biol. 2017;43:156-162. PMID: 28363194. PMC5420475. NIHMS861097.

7. Coric P, Saribas AS, Abou-Gharbia M, et al. Nuclear Magnetic Resonance Structure of the Human Polyoma Jc Virus Agnoprotein. J Cell Biochem. 2017;118(10):3268-3280. PMID: 28295503. PMC5550335. NIHMS860648.

8. Correa AF, Handorf E, Joshi SS, et al. Differences in Survival by Receipt of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2017. PMID: 29248557.

9. Debenedetti PG, Klein ML. Chemical Physics of Water. Proc Natl Acad Sci U S A. 2017;114(51):13325-13326. PMID: 29229822.

10. Evans JD, Hansen CC, Tollefson MK, Hallemeier CL. Stereotactic Body Radiation Therapy for Medically Inoperable, Clinically Localized, Urothelial Carcinoma of the Renal Pelvis: A Case Report. Advances in Radiation Oncology. 2017.

11. Gerstenhaber JA, Barone FC, Marcinkiewicz C, et al. Vascular Thrombus Imaging in Vivo Via near-Infrared Fluorescent Nanodiamond Particles Bioengineered with the Disintegrin Bitistatin (Part Ii). Int J Nanomedicine. 2017;12:8471-8482. PMID: 29200855. PMC5703177.

12. Giri VN, Knudsen KE, Kelly WK, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2017:Jco2017741173. PMID: 29236593.

13. Gupta S, Provenzale D, Regenbogen SE, et al. Nccn Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. J Natl Compr Canc Netw. 2017;15(12):1465-1475. PMID: 29223984.

14. Harshman LC, Chen YH, Liu G, et al. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone Sensitive Prostate Cancer Treated with Androgen Deprivation with or without Docetaxel. J Clin Oncol. 2017:Jco2017753921. PMID: 29261442.

15. Hartmann BM, Albrecht RA, Zaslavsky E, et al. Pandemic H1n1 Influenza a Viruses Suppress Immunogenic Ripk3-Driven Dendritic Cell Death. Nat Commun. 2017;8(1):1931. PMID: 29203926. PMC5715119.

16. He S, Liu Y, Meng L, et al. Ezh2 Phosphorylation State Determines Its Capacity to Maintain Cd8(+) T Memory Precursors for Antitumor Immunity. Nat Commun. 2017;8(1):2125. PMID: 29242551. PMC5730609.

17. In TSH, Trotman-Grant A, Fahl S, et al. Heb Is Required for the Specification of Fetal Il-17-Producing Gammadelta T Cells. Nat Commun. 2017;8(1):2004. PMID: 29222418. PMC5722817.

18. Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med. 2017;14(12):1463-1491. PMID: 29198504.

19. Kline CLB, Ralff MD, Lulla AR, et al. Role of Dopamine Receptors in the Anticancer Activity of Onc201. Neoplasia. 2018;20(1):80-91. PMID: 29216597. PMC5725157.

20. Lazarovici P, Lahiani A, Gincberg G, et al. Nerve Growth Factor-Induced Angiogenesis: 1. Endothelial Cell Tube Formation Assay. Methods Mol Biol. 2018;1727:239-250. PMID: 29222786.

21. Lazarovici P, Lahiani A, Gincberg G, Haham D, Marcinkiewicz C, Lelkes PI. Nerve Growth Factor-Induced Angiogenesis: 2. The Quail Chorioallantoic Membrane Assay. Methods Mol Biol. 2018;1727:251-259. PMID: 29222787.

22. Levy RM, Haldane A, Flynn WF. Potts Hamiltonian Models of Protein Co-Variation, Free Energy Landscapes, and Evolutionary Fitness. Curr Opin Struct Biol. 2017;43:55-62. PMID: 27870991.

23. Li M, Sohn JA, Seeger C. Distribution of Hepatitis B Virus Nuclear DNA. J Virol. 2018;92(1). PMID: 29046450. PMC5730781.

24. Li P, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Med. 2017. PMID: 29195016.

25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an Imrt Patient on a Second Accelerator without Replanning? Med Dosim. 2017. PMID: 29287919.

26. Liu D, Abbosh P, Keliher D, et al. Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer. Nat Commun. 2017;8(1):2193. PMID: 29259186. PMC5736752.

27. Manne SL, Kashy D, Siegel SD, Heckman CJ. Group Therapy Processes and Treatment Outcomes in 2 Couple-Focused Group Interventions for Breast Cancer Patients. Psychooncology. 2017;26(12):2175-2185.

28. Manne SL, Myers-Virtue S, Kashy DA, et al. Therapy Processes, Progress, and Outcomes for 2 Therapies for Gynecological Cancer Patients. Psychooncology. 2017;26(12):2069-2078.

29. Mehrazin R, Dulaimi E, Uzzo RG, et al. The Correlation between Gain of Chromosome 8q and Survival in Patients with Clear and Papillary Renal Cell Carcinoma. Therapeutic Advances in Urology. 2018;10(1):3-10.

30. Meropol NJ, Feng Y, Grem JL, et al. Phase 2 Study of Treatment Selection Based on Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer: A Trial of the Ecog-Acrin Cancer Research Group (E4203). Cancer. 2017. PMID: 29211295.

31. Michael JV, Goldfinger LE. Concepts and Advances in Cancer Therapeutic Vulnerabilities in Ras Membrane Targeting. Semin Cancer Biol. 2017. PMID: 29203271.
32. Mortazavi SMJ. Comment on “Mobile Phone Radiofrequency Exposure Has No Effect on DNA Double Strand Breaks (Dsb) in Human Lymphocytes”. Ann Transl Med. 2017;5(21):441. PMID: 29201892. PMC5690963.

33. Mortazavi SMJ. Comments on “Wi-Fi Radiation Exposures to Children in Kindergartens and Schools – Results Should Lessen Parental Concerns”. Aust N Z J Public Health. 2017. PMID: 29235700.

34. Mortazavi SMJ. Letter to the Editor (July 26, 2017) Concerning the Paper “Impact of Electromagnetic Radiation Emitted by Monitors on Changes in the Cellular Membrane Structure and Protective Antioxidant Effect of Vitamin a – <I>in Vitro</I> Study”. Int J Occup Med Environ Health. 2018;31(3):371-372. PMID: 29209096.

35. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. Int Arch Occup Environ Health. 2017. PMID: 29273973.

36. Nitzkorski JR, Willis AI, Nick D, Zhu F, Farma JM, Sigurdson ER. In Reply: Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer. Ann Surg Oncol. 2017;24(Suppl 3):597. PMID: 29197042.

37. Norquist BM, Brady MF, Harrell MI, et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in Gog 218: An Nrg Oncology/Gynecologic Oncology Group Study. Clin Cancer Res. 2017. PMID: 29191972.

38. Peng H, Prokop J, Karar J, et al. Familial and Somatic Bap1 Mutations Inactivate Asxl1/2-Mediated Allosteric Regulation of Bap1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2017. PMID: 29284740.

39. Peng J, Meireles SI, Xu X, et al. Estrogen Metabolism in the Human Lung: Impact of Tumorigenesis, Smoke, Sex and Race/Ethnicity. Oncotarget. 2017;8(63):106778-106789.

40. Persky DO, Li H, Rimsza LM, et al. A Phase I/Ii Trial of Vorinostat (Saha) in Combination with Rituximab-Chop in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (Dlbcl): Swog S0806. Am J Hematol. 2017. PMID: 29266344.

41. Ristau BT, Kutikov A. Editorial Comment. J Urol. 2017. PMID: 29227811.

42. Ristau BT, Manola J, Haas NB, et al. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the Assure (Ecog-Acrin 2805) Adjuvant Trial. Journal of Urology. 2018;199(1):53-59.

43. Ristau BT, Smaldone MC. Editorial Comment. J Urol. 2017. PMID: 29287168.

44. Roboz GJ, Kantarjian HM, Yee KWL, et al. Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia. Cancer. 2017. PMID: 29211308.

45. Shah AY, Karam JA, Malouf GG, et al. Management and Outcomes of Patients with Renal Medullary Carcinoma: A Multicentre Collaborative Study. BJU Int. 2017;120(6):782-792. PMID: 27860149.

46. Shaikh T, Wang LS, Egleston B, et al. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018;41(1):59-64. PMID: 26325492. PMC4769977. NIHMS712811.

47. Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A. Splice Variants of Human Natural Cytotoxicity Receptors: Novel Innate Immune Checkpoints. Cancer Immunol Immunother. 2017. PMID: 29264698.

48. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A Swog and Blood & Marrow Transplant Clinical Trials Network Phase Ii Trial (Swog S0410/Bmt Ctn 0703). Biol Blood Marrow Transplant. 2017. PMID: 29289757.

49. Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. Ahns Series: Do You Know Your Guidelines? Review of Current Knowledge on Laryngeal Cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2018;40(1):170-181.

50. Vijayvergia N, Cohen SJ. Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed. Current and Emerging Therapies in Pancreatic Cancer 2017:205-217.

51. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2017: PMID: 29220298.

52. Wang TP, Scott JH, Barta SK. The Evolving Role of Targeted Biological Agents in the Management of Indolent B-Cell Lymphomas. Ther Adv Hematol. 2017;8(12):329-344. PMID: 29204260. PMC5703116.

53. Warner EL, Ding Q, Pappas LM, Henry K, Kepka D. White, Affluent, Educated Parents Are Least Likely to Choose Hpv Vaccination for Their Children: A Cross-Sectional Study of the National Immunization Study – Teen. BMC Pediatr. 2017;17(1):200. PMID: 29191180. PMC5710112.

54. Winckworth-Prejsnar K, Nardi EA, McCanney J, et al. Ensuring Patient Safety and Access in Cancer Care. J Natl Compr Canc Netw. 2017;15(12):1460-1464. PMID: 29223983.

55. Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients with Pelvic or Abdominal Recurrence after Treatment for Stage I/Ii Endometrial Carcinoma. Am J Clin Oncol. 2017;40(6):598-604. PMID: 26237194. PMC4733581. NIHMS704405.

56. Xua QY, Fan JJ, Grimm J, et al. The Dosimetric Impact of the Prescription Isodose Line (Idl) on the Quality of Robotic Stereotactic Radiosurgery (Srs) Plans. Medical Physics. 2017;44(12):6159-6165.

57. Zhang YW, Nasto RE, Jablonski SA, et al. Rna Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio Protoc. 2017;7(15). PMID: 29250574. PMC5730085. NIHMS898362.

58. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. Laryngoscope. 2017. PMID: 29238975.

Staff Publications: November 2017

1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointest Endosc. 2017. PMID: 29129525.

2. Adamsky MA, Boysen WR, Dmochowski RR, Bales GT, Cohn JA. Author Reply: Re: Evaluating the Role of Postoperative Oral Antibiotic Administration in Artificial Urinary Sphincter and Inflatable Penile Prosthesis Explantation: A Nationwide Analysis. Urology. 2017. PMID: 29122319.

3. Ashing KT, Carrington A, Ragin C, Roach V. Examining Hpv- and Hpv Vaccine-Related Cognitions and Acceptability among US-Born and Immigrant Hispanics and US-Born and Immigrant Non-Hispanic Blacks: A Preliminary Catchment Area Study. Cancer Causes Control. 2017;28(11):1341-1347. PMID: 29098504.

4. Calvo E, Azaro A, Rodon J, et al. Hepatic Safety Analysis of Trabectedin: Results of a Pharmacokinetic Study with Trabectedin in Patients with Hepatic Impairment and Experience from a Phase 3 Clinical Trial. Invest New Drugs. 2017. PMID: 29177975.

5. Castaneda CA, Wolfson NA, Leng KR, Kuo YM, Andrews AJ, Fierke CA. Histone Deacetylase 8 Substrate Selectivity Is Determined by Long- and Short-Range Interactions Leading to Enhanced Reactivity for Full-Length Histone Substrates Compared to Peptides. J Biol Chem. 2017. PMID: 29109148.

6. Chang WL, Jackson C, Riel S, et al. Differential Preventive Activity of Sulindac and Atorvastatin in Apc(+/Min-Fccc)Mice with or without Colorectal Adenomas. Gut. 2017. PMID: 29122850.

7. Cho JH, Patel B, Bonala S, et al. Notch Transactivates Rheb to Maintain the Multipotency of Tsc-Null Cells. Nat Commun. 2017;8(1):1848. PMID: 29184052.

8. Cuttler J, Mortazavi S, Welsh J, Doss M. Comments on “Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure”. Thyroid. 2017. PMID: 29132249.

9. Dasgupta Y, Golovine K, Nieborowska-Skorska M, et al. Drugging DNA Repair to Target T-All Cells. Leuk Lymphoma. 2017:1-4. PMID: 29115896.

10. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer J Clin. 2017. PMID: 29165798.

11. Di Marcantonio D, Martinez E, Sidoli S, et al. Pkc Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia. Clin Cancer Res. 2017. PMID: 29127121.

12. Dong Y, Zaorsky NG, Li T, et al. Effects of Interruptions of External Beam Radiation Therapy on Outcomes in Patients with Prostate Cancer. Journal of Medical Imaging and Radiation Oncology. 2017.

13. Epperla N, Maddocks KJ, Salhab M, et al. C-Myc-Positive Relapsed and Refractory, Diffuse Large B-Cell Lymphoma: Impact of Additional “Hits” and Outcomes with Subsequent Therapy. Cancer. 2017;123(22):4411-4418. PMID: 28749548.

14. Heckman CJ. Public Parks and Shady Areas in Times of Climate Change, Urban Sprawl, and Obesity. Am J Public Health. 2017;107(12):1856-1858. PMID: 29116832.

15. Huang J, Liu Y, Vitale S, et al. On Meta- and Mega-Analyses for Gene-Environment Interactions. Genet Epidemiol. 2017;41(8):876-886. PMID: 29110346.

16. Isoda T, Moore AJ, He Z, et al. Non-Coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate. Cell. 2017;171(1):103-119.e118.

17. Jung S, Allen N, Arslan AA, et al. Anti-Mullerian Hormone and Risk of Ovarian Cancer in Nine Cohorts. International Journal of Cancer. 2018;142(2):262-270.

18. Kasireddy V, von Mehren M. Emerging Drugs for the Treatment of Gastrointestinal Stromal Tumour. Expert Opin Emerg Drugs. 2017. PMID: 29183145.

19. Kasivisvanathan V, Kutikov A, Manning TG, et al. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2017. PMID: 29128207.

20. Kato N, Kawasoe Y, Williams H, et al. Sensing and Processing of DNA Interstrand Crosslinks by the Mismatch Repair Pathway. Cell Rep. 2017;21(5):1375-1385. PMID: 29091773.

21. Kit OI, Vodolazhsky DI, Kutilin DS, et al. A Proteomics Analysis Reveals 9 up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer Patients. Protein J. 2017;36(6):513-522. PMID: 29128960.

22. Klaassen Z, Arora K, Goldberg H, et al. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. J Urol. 2017. PMID: 29113840.

23. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value in Health. 2017.

24. Komiya Y, Bai Z, Cai N, et al. A Nonredundant Role for the Trpm6 Channel in Neural Tube Closure. Sci Rep. 2017;7(1):15623. PMID: 29142255. PMC5688082.

25. Lazar AJ, McLellan MD, Bailey MH, et al. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-+.

26. Lheureux S, Butler MO, Clarke B, et al. Association of Ipilimumab with Safety and Antitumor Activity in Women with Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma. JAMA Oncol. 2017. PMID: 29145543.

27. Manne SL, Myers-Virtue S, Kissane D, et al. Group-Based Trajectory Modeling of Fear of Disease Recurrence among Women Recently Diagnosed with Gynecological Cancers. Psycho-Oncology. 2017;26(11):1799-1809.

28. Marty R, Kaabinejadian S, Rossell D, et al. Mhc-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. 2017. PMID: 29107334.

29. Meeker CR, Wong YN, Egleston BL, et al. Distress and Financial Distress in Adults with Cancer: An Age-Based Analysis. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(10):1224-1233.

30. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing Donor Site Closure Following Bilateral Breast Reconstruction with Abdominal-Based Free Flaps. J Plast Reconstr Aesthet Surg. 2017. PMID: 29129588.

31. Milano RV, Viale E, Bartel MJ, Notaristefano C, Testoni PA. Resection Outcomes and Recurrence Rates of Endoscopic Submucosal Dissection (Esd) and Hybrid Esd for Colorectal Tumors in a Single Italian Center. Surg Endosc. 2017. PMID: 29098434.

32. Mo X, Zhang H, Preston S, et al. Interferon-Gamma Signaling in Melanocytes and Melanoma Cells Regulates Expression of Ctla-4. Cancer Res. 2017. PMID: 29150430.

33. Moore KN, Martin LP, O’Malley DM, et al. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncol. 2017. PMID: 29098867.

34. Mortazavi SMJ. Comment on “Technology as a Tool to Encourage Young Adults to Sleep and Eat Healthy”. ACSM’s Health and Fitness Journal. 2017;21(6):48.

35. Mortazavi SMJ. Comments on “Incidence of Cancer among Licensed Commercial Pilots Flying North Atlantic Routes”. Environmental Health. 2017;16.

36. Myers RM, Hill BT, Shaw BE, et al. Long-Term Outcomes among 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Diffuse Large B-Cell Lymphoma. Cancer. 2017. PMID: 29125192.

37. Nabors LB, Portnow J, Ammirati M, et al. Nccn Guidelines Insights: Central Nervous System Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017;15(11):1331-1345. PMID: 29118226.

38. Natsuizaka M, Whelan KA, Kagawa S, et al. Interplay between Notch1 and Notch3 Promotes Emt and Tumor Initiation in Squamous Cell Carcinoma. Nat Commun. 2017;8(1):1758. PMID: 29170450. PMC5700926.

39. Necchi A, Pond GR, Pal SK, et al. Bone Metastases as the Only Metastatic Site in Patients with Urothelial Carcinoma: Focus on a Special Patient Population. Clin Genitourin Cancer. 2017. PMID: 29158079.

40. Patt YZ, Murad W, Fekrazad MH, et al. Inst Ox-05-024: First Line Gemcitabine, Oxaliplatin, and Erlotinib for Primary Hepatocellular Carcinoma and Bile Duct Cancers: A Multicenter Phase Ii Trial. Cancer Med. 2017;6(9):2042-2051.

41. Peri S, Izumchenko E, Schubert AD, et al. Nsd1- and Nsd2-Damaging Mutations Define a Subset of Laryngeal Tumors with Favorable Prognosis. Nat Commun. 2017;8(1):1772. PMID: 29176703. PMC5701248.

42. Prabhu VV, Talekar MK, Lulla AR, et al. Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone Onc201 in Hematological Malignancies. Cell Cycle. 2017:1-29. PMID: 29157092.

43. Reese JB, Bober SL, Daly MB. Talking About Women’s Sexual Health after Cancer: Why Is It So Hard to Move the Needle? Cancer. 2017. PMID: 29116655.

44. Ribas A, Dummer R, Puzanov I, et al. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-Pd-1 Immunotherapy. Cell. 2017;170(6):1109-1119.e1110.

45. Sartor O, Vogelzang NJ, Sweeney C, et al. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. Oncologist. 2017. PMID: 29183960.

46. Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients with Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol. 2017:e173580. PMID: 29121143.

47. Somech R, Lev A, Lee YN, et al. Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in Arpc1b. J Immunol. 2017. PMID: 29127144.

48. Sparano JA, Gray R, Oktay MH, et al. A Metastasis Biomarker (Metasite Breast Score) Is Associated with Distant Recurrence in Hormone Receptor-Positive, Her2-Negative Early-Stage Breast Cancer. NPJ Breast Cancer. 2017;3:42. PMID: 29138761. PMC5678158.

49. Stabler CT, Caires LC, Jr., Mondrinos MJ, et al. Enhanced Re-Endothelialization of Decellularized Rat Lungs. Tissue Eng Part C Methods. 2016;22(5):439-450. PMID: 26935764. PMC4870653.

50. Tahrir FG, Shanmughapriya S, Ahooyi TM, et al. Dysregulation of Mitochondrial Bioenergetics and Quality Control by Hiv-1 Tat in Cardiomyocytes. J Cell Physiol. 2018;233(2):748-758. PMID: 28493473. PMC5673531. NIHMS882650.

51. Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with Hiv-Related Lymphoma Treated with Epoch: A Comparison within One Prospective Trial Amc034. Leuk Lymphoma. 2017:1-10. PMID: 29160731.

52. Tetzlaff ED, Hylton HM, DeMora L, Ruth K, Wong YN. National Study of Burnout and Career Satisfaction among Physician Assistants in Oncology: Implications for Team-Based Care. J Oncol Pract. 2017:Jop2017025544. PMID: 29190209.

53. Tomar D, Dong Z, Shanmughapriya S, et al. Mcur1 Is a Scaffold Factor for the Mcu Complex Function and Promotes Mitochondrial Bioenergetics. Cell Rep. 2016;15(8):1673-1685. PMID: 27184846. PMC4880542. NIHMS780541.

54. Tong C, Simhan J. Editorial Comment. J Urol. 2017. PMID: 29097188.
55. Vachani A, Wong YN, Israelite J, et al. Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer. Med Care. 2017;55(12):e131-e136. PMID: 29135776.

56. Vyfhuis MAL, Bhooshan N, Molitoris J, et al. Clinical Outcomes of Black Vs. Non-Black Patients with Locally Advanced Non-Small Cell Lung Cancer. Lung Cancer. 2017;114:44-49. PMID: 29173764.

57. Wahab A, Kesari K, Chaudhary S, et al. Sequential Occurrence of Small Cell and Non-Small Lung Cancer in a Male Patient: Is It a Transformation? Cancer Biol Ther. 2017:1-4. PMID: 29157085.

58. Weinberg DS, Pickhardt PJ, Bruining DH, et al. Computed Tomography Colonography Vs Colonoscopy for Colorectal Cancer Surveillance after Surgery. Gastroenterology. 2017. PMID: 29174927.

59. Wierda WG, Byrd JC, Abramson JS, et al. Hairy Cell Leukemia, Version 2.2018: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(11):1414-1427.

60. Wong YN, Manola J, Hudes GR, et al. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: Ecog-Acrin Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2017. PMID: 29173976.

61. Xu B, Chakraborty H, Yadav VK, Zhang Z, Klein ML, Ren S. Author Correction: Tunable Two-Dimensional Interfacial Coupling in Molecular Heterostructures. Nat Commun. 2017;8(1):1699. PMID: 29150607. PMC5693927.

62. Xu J, Cortellino S, Tricarico R, et al. Thymine DNA Glycosylase (Tdg) Is Involved in the Pathogenesis of Intestinal Tumors with Reduced Apc Expression. Oncotarget. 2017;8(52):89988-89997. PMID: 29163805. PMC5685726.

63. Zhao S, Tang H, Yan D, et al. Dda1 Promotes Stage Iib-Iic Colon Cancer Progression by Activating Nfkappab/Csn2/Gsk-3beta Signaling. Oncotarget. 2016;7(15):19794-19812. PMID: 26942699. PMC4991419.

Staff Publications: October 2017

1. Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of Rac1-Driven Malignant Melanoma by Group a Pak Inhibitors. Oncogene. 2017. PMID: 29059171.

2. Aras S, Zaidi MR. Tameless Traitors: Macrophages in Cancer Progression and Metastasis. Br J Cancer. 2017. PMID: 29065107.

3. Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin Regulates Head and Neck Squamous Cell Carcinoma Invasion by Modulating Matrix Metalloproteases. J Cell Physiol. 2018;233(1):409-421. PMID: 28295306. PMC5592128. NIHMS860681.

4. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2017.06.013. Eur Urol. 2017. PMID: 29032846.

5. Balar AV, Castellano D, O’Donnell PH, et al. First-Line Pembrolizumab in Cisplatin-Ineligible Patients with Locally Advanced and Unresectable or Metastatic Urothelial Cancer (Keynote-052): A Multicentre, Single-Arm, Phase 2 Study. Lancet Oncol. 2017. PMID: 28967485.

6. Bamias A, Tzannis K, Harshman LC, et al. Impact of Contemporary Patterns of Chemotherapy Utilization on Survival in Patients with Advanced Cancer of the Urinary Tract: A Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (Risc). Ann Oncol. 2017. PMID: 29077785.

7. Beatty A, Fink LS, Singh T, et al. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple Negative Breast Cancer. Mol Cancer Ther. 2017. PMID: 29021292.

8. Chen M, Ko HY, Remsing RC, et al. Ab Initio Theory and Modeling of Water. Proc Natl Acad Sci U S A. 2017;114(41):10846-10851. PMID: 28973868. PMC5642722.

9. Dmitrieva O, Grivennikov SI. Microbiota and Cancer: A Complex Equation with a Lot of Exciting Unknowns. Semin Immunol. 2017;32:1-2. PMID: 29078919. Editorial.

10. Dong Y, Zaorsky NG, Li T, et al. Effects of Interruptions of External Beam Radiation Therapy on Outcomes in Patients with Prostate Cancer. J Med Imaging Radiat Oncol. 2017. PMID: 29030906.

11. Dotan E. Adjusting Our Current Practice to Better Care for the Older Patient with Cancer. J Oncol Pract. 2017;13(2):103-104. PMID: 28972828.

12. Esposito AC, Crawford J, Sigurdson ER, et al. Omission of Radiotherapy after Breast Conservation Surgery in the Postneoadjuvant Setting. Journal of Surgical Research. 2018;221:49-57.

13. Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL. Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report. Pancreas. 2017;46(10):1381-1385. PMID: 29040196.

14. Gregory K, Schiech L. Helping Patients Cope with Secondary Lymphedema. Nursing. 2017.

15. Gregory K, Schiech L. Looking into Secondary Lymphedema. Nursing. 2017;47(11):34-42. PMID: 28991070.

16. Horn L, Spigel DR, Vokes EE, et al. Nivolumab Versus Docetaxel in Previously Treated Patients with Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes from Two Randomized, Open-Label, Phase Iii Trials (Checkmate 017 and Checkmate 057). J Clin Oncol. 2017:Jco2017743062. PMID: 29023213.

17. Ingram JP, Brodsky IE, Balachandran S. Interferon-Gamma in Salmonella Pathogenesis: New Tricks for an Old Dog. Cytokine. 2017;98:27-32.

18. Jain R, Denlinger CS. Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions. Obesity (Silver Spring). 2017;25 Suppl 2:S27-s29. PMID: 29086512.

19. Johnson N, Liao JB. Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium. Int J Gynecol Cancer. 2017. PMID: 29040190.

20. Kischkel S, Bergt S, Brock B, et al. In Vivo Testing of Extracorporeal Membrane Ventilators: Ila-Activve Versus Prototype I-Lung. Asaio j. 2017;63(2):185-192. PMID: 28092273.

21. Lee HO, Uzzo RG, Kister D, Kruger WD. Combination of Serum Histidine and Plasma Tryptophan as a Potential Biomarker to Detect Clear Cell Renal Cell Carcinoma. J Transl Med. 2017;15(1):72. PMID: 28385150. PMC5383954.

22. Lev A, Deihimi S, Shagisultanova E, et al. Preclinical Rationale for Combination of Crizotinib with Mitomycin C for the Treatment of Advanced Colorectal Cancer. Cancer Biology and Therapy. 2017:1-11.

23. Lev A, Lulla AR, Wagner J, et al. Anti-Pancreatic Cancer Activity of Onc212 Involves the Unfolded Protein Response (Upr) and Is Reduced by Igf1-R and Grp78/Bip. Oncotarget. 2017;8(47):81776-81793.

24. Li JG, Barrero C, Merali S, Pratico D. Genetic Absence of Alox5 Protects from Homocysteine-Induced Memory Impairment, Tau Phosphorylation and Synaptic Pathology. Hum Mol Genet. 2017;26(10):1855-1862. PMID: 28334897.

25. Li M, Sohn JA, Seeger C. Distribution of Hepatitis B Virus Nuclear DNA. J Virol. 2017. PMID: 29046450.

26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of Cgas-Sting Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551.

27. Liu Y, Yuelling LW, Wang Y, et al. Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion. Cancer Res. 2017. PMID: 28986380.

28. Lulla AR, Slifker MJ, Zhou Y, et al. Mir-6883 Family Mirnas Target Cdk4/6 to Induce G1 Phase Cell Cycle Arrest in Colon Cancer Cells. Cancer Res. 2017. PMID: 29061672.

29. Lyubitelev AV, Studitsky VM, Feofanov AV, Kirpichnikov MP. Effect of Sodium and Potassium Ions on Conformation of Linker Parts of Nucleosomes. Moscow University Biological Sciences Bulletin. 2017;72(3):146-150.

30. Maifrede S, Magimaidas A, Sha X, Mukherjee K, Liebermann DA, Hoffman B. Loss of Egr1, a Human Del5q Gene, Accelerates Bcr-Abl Driven Chronic Myelogenous Leukemia. Oncotarget. 2017;8(41):69281-69294. PMID: 29050203. PMC5642478.

31. Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case Series of Multiple Primary Cancers in Single Individuals: Diagnostic and Therapeutic Dilemmas. J Community Hosp Intern Med Perspect. 2017;7(4):238-240. PMID: 29046751. PMC5637644.

32. Mateos-Gomez PA, Kent T, Deng SK, et al. The Helicase Domain of Poltheta Counteracts Rpa to Promote Alt-Nhej. Nat Struct Mol Biol. 2017. PMID: 29058711.

33. Mesa RA, Jamieson C, Bhatia R, et al. Nccn Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. J Natl Compr Canc Netw. 2017;15(10):1193-1207. PMID: 28982745.

34. Michailidou K, Lindstrom S, Dennis J, et al. Association Analysis Identifies 65 New Breast Cancer Risk Loci. Nature. 2017. PMID: 29059683.

35. Milne RL, Kuchenbaecker KB, Michailidou K, et al. Identification of Ten Variants Associated with Risk of Estrogen-Receptor-Negative Breast Cancer. Nat Genet. 2017. PMID: 29058716.

36. Mortazavi G, Mortazavi SAR, Mortazavi SMJ. Comments on “Association of Excessive Mobile Phone Use During Pregnancy with Birth Weight: An Adjunct Study in Kumamoto of Japan Environment and Children’s Study”. Environmental Health and Preventive Medicine. 2017;22(1).

37. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Phys Med. 2017. PMID: 29032028.

38. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body Gamma-Irradiated Mice”. Environ Mol Mutagen. 2017. PMID: 29067715.

39. Mortazavi SMJ. Comments on “Study of Bacterial Contamination of Mobile Phones and Stethoscopes in Neonatal Intensive Care Unit”. International Journal of Pediatrics. 2017;5(11):6143-6144.

40. Mortazavi SMJ. Comments on Analysis of Mobile Phone Use among Young Patients with Brain Tumors in Japan. Bioelectromagnetics. 2017. PMID: 28980326.

41. Mortazavi SMJ. Re: “Modeled and Perceived Exposure to Radiofrequency Electromagnetic Fields from Mobile-Phone Base Stations and the Development of Symptoms over Time in a General Population Cohort”. Am J Epidemiol. 2017:1. PMID: 29036398.

42. Mortazavi SMJ. Re: Are Electromagnetic Fields in Incubators a Risk Factor for Autism? Acta Paediatrica, International Journal of Paediatrics. 2017.

43. Mortazavi SMJ, Mortazavi G, Paknahad M. Comment on Sundseth Et Al. Global Sources and Pathways of Mercury in the Context of Human Health. Int. J. Environ. Res. Public Health 2017, 14, 105. Int J Environ Res Public Health. 2017;14(5). PMID: 28475133. PMC5451932.

44. Mustian KM, Peppone LJ, Miller SM. Difficulties in Defining and Measuring Cancer-Related Fatigue-Reply. JAMA Oncol. 2017. PMID: 28983561.

45. Naaman H, Rall G, Matullo C, Veksler-Lublinsky I, Shemer-Avni Y, Gopas J. Mirna-124 Is a Link between Measles Virus Persistent Infection and Cell Division of Human Neuroblastoma Cells. PLoS One. 2017;12(10):e0187077. PMID: 29073265.

46. Nieborowska-Skorska M, Maifrede S, Dasgupta Y, et al. Ruxolitinib-Induced Defects in DNA Repair Cause Sensitivity to Parp Inhibitors in Myeloproliferative Neoplasms. Blood. 2017. PMID: 29042365.

47. Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program from Theory through Implementation and Assessment. Rehabilitation Oncology. 2017;35(4):172-180.

48. Paudyal SC, Li S, Yan H, Hunter T, You Z. Dna2 Initiates Resection at Clean DNA Double-Strand Breaks. Nucleic Acids Res. 2017. PMID: 28981724.

49. Pelosi G, Sonzogni A, Harari S, et al. Classification of Pulmonary Neuroendocrine Tumors: New Insights. Translational Lung Cancer Research. 2017;6(5):513-529.

50. Pickhardt PJ, Edwards K, Bruining DH, et al. Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: Ct Colonography Versus Optical Colonoscopy and Implications for Patient Care. Dis Colon Rectum. 2017;60(11):1162-1167. PMID: 28991080. PMC5635837. NIHMS860683.

51. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2017. PMID: 29079937.

52. Ragin C, Blackman E, Roberts R, et al. Cancer in Populations of African Ancestry: Studies of the African Caribbean Cancer Consortium. Cancer Causes Control. 2017. PMID: 29086217.

53. Ralff MD, Lulla AR, Wagner J, El-Deiry WS. Onc201: A New Treatment Option Being Tested Clinically for Recurrent Glioblastoma. Translational Cancer Research. 2017;6:S1239-S1243.

54. Ristau BT, Chen DYT, Ellis J, et al. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. J Urol. 2017. PMID: 28988963.

55. Salem ME, Weinberg BA, Xiu J, et al. Comparative Molecular Analyses of Left-Sided Colon, Right-Sided Colon, and Rectal Cancers. Oncotarget. 2017;8(49):86356-86368. PMID: WOS:000413077800145.

56. Seo HS, Habas R, Chang C, Wang J. Bimodal Regulation of Dishevelled Function by Vangl2 During Morphogenesis. Hum Mol Genet. 2017;26(11):2053-2061. PMID: 28334810.

57. Shastri A, Janakiram M, Mantzaris I, et al. Sites of Extranodal Involvement Are Prognostic in Patients with Stage 1 Follicular Lymphoma. Oncotarget. 2017;8(45):78410-78418. PMID: WOS:000412111300022.

58. Shi X, Ba R, You H, et al. A Rare Case of B-Lymphoproliferative Disorder with Villous Lymphocytes Harboring T(8;14)(Q24;Q32) Translocation. Front Med. 2017. PMID: 29075958.

59. Spiess PE, Agarwal N, Bangs R, et al. Bladder Cancer, Version 5.2017. Journal of the National Comprehensive Cancer Network. 2017;15(10):1240-1267.

60. Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. Ahns Series: Do You Know Your Guidelines? Review of Current Knowledge on Laryngeal Cancer. Head Neck. 2017. PMID: 29076227.

61. Tawbi HA, Burgess M, Bolejack V, et al. Pembrolizumab in Advanced Soft-Tissue Sarcoma and Bone Sarcoma (Sarc028): A Multicentre, Two-Cohort, Single-Arm, Open-Label, Phase 2 Trial. Lancet Oncol. 2017. PMID: 28988646.

62. Ursu O, Gosline SJC, Beeharry N, et al. Network Modeling of Kinase Inhibitor Polypharmacology Reveals Pathways Targeted in Chemical Screens. PLoS One. 2017;12(10):e0185650. PMID: 29023490. PMC5638242.

63. Xu Q, Fan J, Grimm J, et al. The Dosimetric Impact of the Prescription Isodose Line (Idl) on the Quality of Robotic Stereotactic Radiosurgery (Srs) Plans. Med Phys. 2017. PMID: 29064585.

64. Zeng K, Tian L, Sirek A, et al. Pak1 Mediates the Stimulatory Effect of Insulin and Curcumin on Hepatic Chrebp Expression. J Mol Cell Biol. 2017. PMID: 28992163.

Is this Journal Legitimate?

Every now and then someone forwards an email from a publisher inviting him or her or them to review submissions, submit an article, or be on the editorial board of a journal. I start reading and three things jump out at me:

  • Reputable journals and conferences don’t email you out of the blue.
  • This email is not very well written.
  • Considering that the representative from this journal is contacting this clinician/researcher for the first time, it’s very informal.

There have been unscrupulous publishers for as long as there have been publishers. They are in the minority but their numbers are growing, and they are becoming more sophisticated. The following are some of the things we look for:

The Journal

  • Does the journal have an valid ISSN?
    • Why does this matter? When a publisher applies for an ISSN, they must provide information and supporting documentation to the ISSN International Centre including: title, frequency, publisher’s name, and medium along with copies of the title page, cover page, editorial page, PDF or JPG of the jacket (if the publication is on CD-ROM), and the URL if the journal is online. Publishers can apply for an ISSN in advance of publication. If the journal does not have an ISSN, be wary of the publisher.
  • Is the current issue available online?
    • Are any back issues available online? If so, does the content look credible? Do you recognize any of the authors?
  • Are their copyright policies, open access policies (where applicable), and peer-review policies and processes explained clearly?
    • More and more predatory journals are putting these policies online. Make sure they make sense and weigh them carefully against other factors, like lacking an ISSN.
  • If the journal boasts an Impact Factor or an Eigenfactor, can it be verified through Journal Citation Reports or Eigenfactor.org, respectively?
    • The Talbot Library subscribes to Journal Citation Reports. The Eigenfactor can be verified at Eigenfactor.org.
  • If the journal claims to be indexed in a particular database (PubMed, Web of Science, SCOPUS, EMBASE) search any or all of those databases to verify the claim.
    • Unscrupulous publishers have been known to create false indexes and claim their journal is indexed there. Something else to keep in mind is every once in a while an article from a predatory journal does make its way into a database.

The Publisher

  • Does the publisher provide full, verifiable contact information including the street address, a working email address, and a working telephone number either in the email message or on the Web site?
    • If you are unsure of the publisher’s veracity, you are well within your rights to phone or email. I prefer phoning, myself. Last time I phoned a questionable publisher, I was bounced into a random, numbered voicemail.
  • If the journal charges publication fees, are they stated up-front and explained clearly?
  • Does the publisher have a Web site? Are the pages within that site stable?
  • On the Web site, check for language use, grammatical errors, and typographical errors. Is the language stilted? Overly formal? Strangely inappropriate?
    • I once ran across a publisher who took great pains to state that they were an American publishing organization, as opposed to an American publisher. Yet they used the British spelling of gynecological.
    • This same publisher described a nursing journal as follows, “Nursing, the word itself reflects a “care” in it and can be treated as the most divine and dedicated professional science that helps patients in the severely ill circumstances from the time of birth till death.”
  • Is the publisher listed in Ulrich’s or  SHERPA/Romeo?
    • Ulrich’s and SHERPA/Romeo will tell you where a publisher is headquartered, where a journal is indexed, how often new issues are released (frequency), and more. SHERPA/Romeo is available free online but ask one of us in the library to search Ulrich’s.

What can I do?

  • Be very wary of unsolicited contact from a publisher with whom you are not familiar.
  • Don’t agree to review submissions, submit articles, or join an editorial board of a journal you do not recognize.
  • Check any claims made by the publisher, be they impact factor, member of an editorial board, or incluion in an index or database like Web of Science or PubMed.
  • Keep your online presence current and accurate.
    • Keeping your professional information up to date makes it easier for others to do the due diligence when they are researching a suspect journal.
  • Have you been fooled by a predatory publisher, tell your colleagues.
  • When in doubt about a journal, publisher, or conference, talk to a librarian.
    • Librarians are trained to find and evaluate information. If you have doubts come talk to us, we can look into the publisher for you.